## COR: Cencora, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -2.9% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($326.84)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Cencora to Acquire OneOncology to Expand Community Oncology Solutions**
- Source: Finviz | 20251219T174208 | Somewhat-Bullish | Relevance: 100%
- Cencora, Inc. (COR) has agreed to acquire a majority of OneOncology, a physician-led national platform supporting independent oncology practices, for $3.6 billion, expanding its strategic control and advancing its pharmaceutical-centric strategy. This acquisition is expected to strengthen Cencora's support for specialty physicians and pharmaceutical innovators, enhance cancer care, and contribute to the growing oncology market. Cencora has also raised its long-term guidance for adjusted operating income and diluted EPS growth for its U.S. Healthcare Solutions segment.

**2. Czech National Bank Purchases 7,075 Shares of Cencora, Inc. $COR**
- Source: MarketBeat | 20251219T092909 | Bullish | Relevance: 100%
- The Czech National Bank has increased its stake in Cencora, Inc. (NYSE:COR) by 16.8%, purchasing an additional 7,075 shares, bringing its total holdings to 49,240 shares valued at approximately $15.39 million. Institutional investors now own about 97.52% of the company's stock. Cencora has also seen positive analyst ratings, a dividend increase, and slightly beat its quarterly EPS estimates.

**3. Texas Permanent School Fund Corp Has $3.63 Million Holdings in Cencora, Inc. $COR**
- Source: MarketBeat | 20251219T104015 | Bullish | Relevance: 100%
- Texas Permanent School Fund Corp reduced its stake in Cencora, Inc. ($COR) by 37.2%, selling 7,186 shares and retaining holdings valued at $3.634 million. This comes as Cencora reported strong quarterly earnings, beating estimates with $3.84 EPS, raising its dividend to $0.60 per quarter, and receiving a "Moderate Buy" consensus analyst rating. Insider selling by CEO Robert P. Mauch also occurred, reducing his ownership by 11.84%.

**4. \Osaic Holdings Inc. Buys 9,171 Shares of Cencora, Inc. $COR**
- Source: MarketBeat | 20251219T103415 | Somewhat-Bullish | Relevance: 100%
- Osaic Holdings Inc. increased its stake in Cencora, Inc. by 24.8% during the second quarter, bringing its total holdings to 46,185 shares valued at approximately $13.86 million. Several Wall Street analysts have raised price targets for Cencora, and the company recently increased its quarterly dividend to $0.60 per share. Insiders, including CEO Robert P. Mauch, have also been active in selling shares.

**5. Thurston Springer Miller Herd & Titak Inc. Decreases Position in Cencora, Inc. $COR**
- Source: MarketBeat | 20251217T142710 | Somewhat-Bullish | Relevance: 100%
- Thurston Springer Miller Herd & Titak Inc. significantly reduced its stake in Cencora, Inc. (NYSE:COR) by 93.6% in the third quarter of 2025, selling 8,838 shares and retaining 602. Despite this, analyst sentiment remains largely positive, with several firms raising price targets and the stock holding a "Moderate Buy" consensus. Cencora also reported strong Q3 earnings, beating estimates, and increased its quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $400 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+4.1%)
- Blackrock Inc.: 10.2% (+5.7%)
- JPMORGAN CHASE & CO: 4.8% (+139.5%)
- State Street Corpora: 4.7% (+9.3%)
- Price (T.Rowe) Assoc: 4.0% (-0.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.0% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.92 indicates undervaluation relative to growth. Quality metrics strong (ROE 124%). Balance sheet: $2.9B free cash flow. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $66.1B |
| Beta | 0.63 |
| 52W Range | $223.92 - $377.54 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.92 |
| Forward P/E | 17.5 |
| Current P/E | 19.4 |
| YoY Growth | 11.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.9% to -2.9% (-2.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.9pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.12x) but short-term weakness (below SMA20). MACD histogram bearish (-1.34), momentum weakening. RSI neutral at 44. OFD pattern: -DBH (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.89% (CS: 22) | Weak |
| RSI_14 | 44.0 | Neutral |
| MACD Histogram | -1.34 | Bearish |
| vs SMA20 | 0.975x | Below |
| vs SMA50 | 0.987x | Below |
| vs SMA200 | 1.124x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $340.94
- **Stop Loss:** $326.84 (4.1% risk)
- **Target:** $355.04 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 85
- **Position Value:** $28,979.90
- **Portfolio %:** 28.98%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-04 (Est: $4.07)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.79 | $3.84 | +1.4% |
| 2025Q2 | $3.84 | $4.00 | +4.2% |
| 2025Q1 | $4.10 | $4.42 | +7.9% |
| 2024Q4 | $3.52 | $3.73 | +6.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*